Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Find effective ways to increase cash back from your credit cards. Boost your rewards and make every purchase count.
23,532 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
Circle stock surged after first-quarter results beat expectations and a fresh Arc funding round. This Morning Minute ...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
Viking Holdings has doubled its value in the past year, a standout move in the cruising sector. This article breaks d...
Micron stock crashed today, sparking a flurry of questions about memory pricing and AI-driven demand. This guide brea...
June market swings have hit chip names hard, but the smarter money is shifting toward a single AI-dominant tech heavy...
When a company’s founder and CEO sells a chunk of stock, investors want to know what it means for future performance....
NVIDIA stock hasn't been this affordable in years, but cheap price tags don't guarantee gains. This guide breaks down...
A transformative update could reshape Micron stock dynamics. This guide breaks down what the news might mean, how to ...
NVIDIA faces bearish chatter, yet supporters argue three durable drivers could lift the stock. AI demand, cash return...